BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis

AR Brunoni, C Baeken, R Machado-Vieira… - The World Journal of …, 2014 - Taylor & Francis
Objectives. To evaluate whether electroconvulsive therapy (ECT), a very effective non-
pharmacological treatment for mood disorders, induces neurotrophic effects, indexed by the …

The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment

MJ Minzenberg, AF Leuchter - Journal of Affective Disorders, 2019 - Elsevier
Objective Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment for
neuropsychiatric disorders. Patients in rTMS treatment typically receive concomitant …

Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression

C Spampinato, E Aguglia, C Concerto… - IEEE transactions on …, 2013 - ieeexplore.ieee.org
Major depression is one of the leading causes of disabling condition worldwide and its
treatment is often challenging and unsatisfactory, since many patients become refractory to …

Biomarkers obtained by transcranial magnetic stimulation of the motor cortex in epilepsy

M Tsuboyama, H Lee Kaye… - Frontiers in integrative …, 2019 - frontiersin.org
Epilepsy is associated with numerous neurodevelopmental disorders. Transcranial
magnetic stimulation (TMS) of the motor cortex coupled with electromyography (EMG) …

Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs

T Hebel, MA Abdelnaim, M Deppe, PM Kreuzer… - European Archives of …, 2021 - Springer
Introduction The effect of concomitant medication on repetitive transcranial magnetic
stimulation (rTMS) outcomes in depression remains understudied. Recent analyses show …

Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double‐blind, placebo‐controlled, cross‐over study

TQ Ruijs, JAAC Heuberger… - British journal of …, 2022 - Wiley Online Library
Aims The purpose of this study was to investigate pharmacodynamic effects of drugs
targeting cortical excitability using transcranial magnetic stimulation (TMS) combined with …

Early TMS evoked potentials in epilepsy: A pilot study

EM Ter Braack, AWE Koopman… - Clinical …, 2016 - Elsevier
Objective To explore if the TMS evoked potential is different in patients with epilepsy
compared to healthy subjects. Methods Eighteen healthy subjects and thirteen epilepsy …

[HTML][HTML] Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study

N Lang, H Rothkegel, H Peckolt, G Deuschl - Seizure, 2013 - Elsevier
Purpose Lacosamide (LCM) and carbamazepine (CBZ) are antiepileptic drugs both acting
on neuronal voltage-gated sodium channels. Patch-clamp studies demonstrated significant …

Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability

G Martinotti, C Montemitro, M Pettorruso… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Mood stabilizers and antipsychotics have been demonstrated to be effective in
Bipolar Disorder, with lithium as the gold standard. However, the presence of adverse …

Alterations of motor cortical excitability and anatomy in Unverricht‐Lundborg disease

N Danner, P Julkunen, J Hyppönen… - Movement …, 2013 - Wiley Online Library
Unverricht‐Lundborg disease is the most common form of progressive myoclonus
epilepsies. In addition to generalized seizures, it is characterized by myoclonus, which …